Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice.

Leonard E EgedeAlina BogdanovLauren FischerJoão Diogo Da Rocha FernandesLee Kallenbach

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

Consistent with previous real-world studies, IDegLira lowered HbA1c across different background prior glucose-lowering therapies, with minimal impact on weight.

Keyphrases

glycemic control
blood glucose
type diabetes
weight loss
primary care
healthcare
body mass index
physical activity
insulin resistance
weight gain
case control
quality improvement
blood pressure
stem cells
metabolic syndrome
skeletal muscle
chemotherapy induced